Document is current
Any future updates will be listed below
-
Authors
Adler, Benjamin A. https://orcid.org/0000-0002-7488-3040
Al-Shimary, Muntathar J.
Patel, Jaymin R.
Armbruster, Emily G. https://orcid.org/0000-0003-0377-1209
Colognori, David
Charles, Emeric J.
Miller, Kate V. https://orcid.org/0000-0002-5315-4172
Lahiri, Arushi
Cui, Michael L.
Oromí-Bosch, Agnès
Voelker, Angela
Trinidad, Marena https://orcid.org/0000-0001-7839-4642
Lee, Jina
Beurnier, Sebastien
Boger, Ron https://orcid.org/0000-0002-4467-271X
Nomburg, Jason
Barrangou, Rodolphe https://orcid.org/0000-0002-0648-3504
Mutalik, Vivek K. https://orcid.org/0000-0001-7934-0400
Schoeniger, Joseph S.
Pogliano, Joseph A. https://orcid.org/0000-0001-8989-2655
Savage, David F. https://orcid.org/0000-0003-0042-2257
Doudna, Jennifer A. https://orcid.org/0000-0001-9161-999X
Cress, Brady F. https://orcid.org/0000-0002-2948-2846
- License Information
-
More Information
Article History
Received: 17 October 2024
Accepted: 14 January 2025
First Online: 26 February 2025
Competing interests
: The Regents of the University of California have patents pending related to this work on which B.A.A., M.J.A.-S., J.R.P., E.G.A., J.L., E.J.C., J.A.P., D.F.S., J.A.D., and B.F.C. are inventors. J.A.D. is a co-founder of Caribou Biosciences, Editas Medicine, Intellia Therapeutics, Scribe Therapeutics, Mammoth Biosciences, Evercrisp and Azalea; a scientific advisory board member of Caribou Biosciences, Scribe Therapeutics, Mammoth and Inari; and a Director at Johnson & Johnson, Tempus and Altos Labs. R. Barrangou. is a shareholder of Caribou Biosciences, Intellia Therapeutics, Locus Biosciences, Inari, TreeCo, and Ancilia Biosciences. The other authors declare no competing interests.
